MOVING IN UNISON
We work as a flexible, attentive extension of your team; we offer the contract research organization services you need to move your molecule from preclinical to Phase I, Phase II, and beyond.
Your Road to Proactive Drug Development Starts Here...
Scientifically focused, integrated, efficient, and cost-effective — this is our approach to early phase drug development that gets you to clinical proof of concept faster.
Altasciences Acquires WCCT Global
We are expanding our current clinical operations in Montreal and Kansas City with the acquisition of a clinical CRO on the U.S.A.'s West Coast. Click below to learn about WCCT Global.
What is Altasciences' Tell Us Once™ Approach?
Tell Us Once™ is our commitment to proactively sharing your preferences, requirements, and relevant program information across Altasciences teams, so that you don't have to repeat yourself.
We are a forward-thinking, mid-size early phase contract research organization, in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development, including preclinical safety testing, clinical pharmacology (Phase I to Phase II), bioanalysis (preclinical to Phase IV), research services, and manufacturing and analytical services.
Focused on your success … always available and always looking ahead ... moving in unison to deliver big impact with a personal touch.
WHAT WE DO
We help you reach early phase drug development decision-making milestones sooner, improving speed and ease from lead candidate selection to proof of concept, and beyond.
Safety assessments for both small and large molecules
Clinical pharmacology trials from first-in-human to end of Phase II
From formulation development, Phase I through commercial manufacturing, and ICH stability testing
Package or stand-alone. Preclinical, Phase I to Phase IV bioanalytical laboratories
Comprehensive CRO services to support clinical and preclinical studies
OPPORTUNITY CAREER GROWTH WORK LIFE
Careers at Altasciences
No important medicine is developed by one person. Early phase drug development takes teams of dedicated individuals, working in synergy, to create something that transforms lives. Together, we work hard, have fun, and innovate continuously, getting medicines to the people who need them, faster.
…an important partner in our development efforts and we recommend them for any ligand-binding requirements.
I … commend Altasciences on their scientific knowledge, efficient and timely processes, and excellent customer service.
It was easy to work with them and they were always willing to take the time to discuss any concerns and respond to questions.
I recommend this site because of the expertise and quality of trials performed.
...the communication between our teams was optimal, from the first protocol draft to the delivery of final report.
We have been very pleased with their record of timely recruitment, including ensuring an inventory of back-up study participants.